Tuesday, March 29, 2016

BRIEF-Sinclair Pharma sees Q3 revenue to exceed 8 mln stg

* As expected, reported sales at 7.7 mln stg (H1 FY15: 10.5 mln stg) were lower in H1 as a result of planned distributor de-stocking











Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)